Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Florence Joly

Showing results (161-170 of 347) with videos related to

Pageof 35
Sort By:
Bulletin Du Cancer|August 12, 2023
Jérôme Alexandre, Marie-Aude Le Frère-Belda, Antoine Angelergues, et al.
Nature Communications|February 20, 2025
Olaparib combined to metronomic cyclophosphamide and metformin in women with recurrent advanced/metastatic endometrial cancer: the ENDOLA phase I/II trialMax Piffoux, Alexandra Leary, Philippe Follana, et al.
Gynecologic Oncology|August 9, 2020
Primary results from CECILIA, a global single-arm phase II study evaluating bevacizumab, carboplatin and paclitaxel for advanced cervical cancerAndres Redondo, Nicoletta Colombo, Mary McCormack, et al.
Breast Cancer Research : BCR|June 5, 2024
Inflammation at diagnosis and cognitive impairment two years later in breast cancer patients from the Canto-Cog studyMylène Duivon, Justine Lequesne, Antonio Di Meglio, et al.
Cancers|September 23, 2022
A <i>Panax quinquefolius</i>-Based Preparation Prevents the Impact of 5-FU on Activity/Exploration Behaviors and Not on Cognitive Functions Mitigating Gut Microbiota and Inflammation in MiceRenaud Parment, Martine Dubois, Laurence Desrues, et al.
BMC Cancer|November 26, 2022
TALASUR trial: a single arm phase II trial assessing efficacy and safety of TALazoparib and Avelumab as maintenance therapy in platinum-Sensitive metastatic or locally advanced URothelial carcinomaElodie Coquan, Bénédicte Clarisse, Justine Lequesne, et al.
European Urology Focus|July 21, 2017
Prospective Evaluation of the Impact of Antiangiogenic Treatment on Cognitive Functions in Metastatic Renal CancerFlorence Joly, Natacha Heutte, Brigitte Duclos, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|May 8, 2023
Evaluation of Scores to Reflect Toxicity Impact on Quality of Life of Patients With Platinum-Resistant Ovarian Cancer: AURELIA SubstudyJustine Lequesne, Florence Joly, Julien Peron, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|November 22, 2016
A Phase 2, Randomized, Open-Label Study of Irosustat Versus Megestrol Acetate in Advanced Endometrial CancerPatricia Pautier, Ignace Vergote, Florence Joly, et al.
BMC Complementary Medicine and Therapies|May 31, 2024
Digital cognitive stimulation in elderly breast cancer patients: the Cog-Tab-Age feasibility studyGiulia Binarelli, Marie Lange, Mélanie Dos Santos, et al.
Pageof 35

Showing results (161-170 of 347) with videos related to

Sort By:
Pageof 35
Bulletin Du Cancer|August 12, 2023
Jérôme Alexandre, Marie-Aude Le Frère-Belda, Antoine Angelergues, et al.
Nature Communications|February 20, 2025
Olaparib combined to metronomic cyclophosphamide and metformin in women with recurrent advanced/metastatic endometrial cancer: the ENDOLA phase I/II trialMax Piffoux, Alexandra Leary, Philippe Follana, et al.
Gynecologic Oncology|August 9, 2020
Primary results from CECILIA, a global single-arm phase II study evaluating bevacizumab, carboplatin and paclitaxel for advanced cervical cancerAndres Redondo, Nicoletta Colombo, Mary McCormack, et al.
Breast Cancer Research : BCR|June 5, 2024
Inflammation at diagnosis and cognitive impairment two years later in breast cancer patients from the Canto-Cog studyMylène Duivon, Justine Lequesne, Antonio Di Meglio, et al.
Cancers|September 23, 2022
A <i>Panax quinquefolius</i>-Based Preparation Prevents the Impact of 5-FU on Activity/Exploration Behaviors and Not on Cognitive Functions Mitigating Gut Microbiota and Inflammation in MiceRenaud Parment, Martine Dubois, Laurence Desrues, et al.
BMC Cancer|November 26, 2022
TALASUR trial: a single arm phase II trial assessing efficacy and safety of TALazoparib and Avelumab as maintenance therapy in platinum-Sensitive metastatic or locally advanced URothelial carcinomaElodie Coquan, Bénédicte Clarisse, Justine Lequesne, et al.
European Urology Focus|July 21, 2017
Prospective Evaluation of the Impact of Antiangiogenic Treatment on Cognitive Functions in Metastatic Renal CancerFlorence Joly, Natacha Heutte, Brigitte Duclos, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|May 8, 2023
Evaluation of Scores to Reflect Toxicity Impact on Quality of Life of Patients With Platinum-Resistant Ovarian Cancer: AURELIA SubstudyJustine Lequesne, Florence Joly, Julien Peron, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|November 22, 2016
A Phase 2, Randomized, Open-Label Study of Irosustat Versus Megestrol Acetate in Advanced Endometrial CancerPatricia Pautier, Ignace Vergote, Florence Joly, et al.
BMC Complementary Medicine and Therapies|May 31, 2024
Digital cognitive stimulation in elderly breast cancer patients: the Cog-Tab-Age feasibility studyGiulia Binarelli, Marie Lange, Mélanie Dos Santos, et al.
Pageof 35